Amgen Inc.AMGNNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank79
5Y CAGR+50.3%
Year-over-Year Change
Year-over-year research & development expense growth
5Y CAGR
+50.3%/yr
Long-term compound
Percentile
P79
Within normal range
vs 5Y Ago
7.7x
Strong expansion
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 16.93% |
| 2024 | 24.67% |
| 2023 | 7.89% |
| 2022 | -29.89% |
| 2021 | 50.32% |
| 2020 | 2.21% |
| 2019 | 10.14% |
| 2018 | 4.91% |
| 2017 | -7.24% |
| 2016 | -5.65% |